T-cell anergy may serve to limit autoreactive T-cell responses *in vivo*. Anergy induction *in vitro*is blocked by calcineurin inhibitors and by inhibition of protein synthesis. In order to look for a potential anergy specific gene, we examined early changes in gene expression in murine CD4^+^T-cell clones after antigen-T-cell receptor signaling in the presence (activation) or absence (anergy) of B7 co-stimulation. *GRAIL*(Gene Related to Anergy in Lymphocytes) was a novel transcript whose expression was markedly induced in anergic T cells *in vitro*compared with activated or resting T cells. GRAIL is a novel murine type I transmembrane protein that localizes to the endocytic pathway and bears homology to several RING Zinc-finger proteins. GRAIL functions as an E3 ubiquitin ligase. Expression of GRAIL in retrovirally transduced T-cell hybridomas dramatically limits activation-induced IL-2 production *in vitro*. Substitution of histidine for asparagine at two positions in the ring finger (H2N2 GRAIL) blocks enzymatic function of GRAIL. Retroviral transduction of hematopoietic stem cells to express *GRAIL*reiterates the anergy phenotype in resultant CD4^+^T cells, including inability to secrete IL-2 or proliferate following antigen stimulation. Expression of the enzymatically inactive (dominant-negative) form of *H2N2 GRAIL*blocks anergy induction in T cells *in vivo*. These data demonstrate that GRAIL is necessary and sufficient to induce anergy in CD4^+^T cells.
